Skip to Main content Skip to Navigation
Journal articles

Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.: Hormone therapy and venous thromboembolism

Abstract : Oral estrogen therapy increases venous thromboembolism risk among postmenopausal women. Although recent data showed transdermal estrogens may be safe with respect to thrombotic risk, the impact of the route of estrogen administration and concomitant progestogens is not fully established. We used data from the E3N French prospective cohort of women born between 1925 and 1950 and biennially followed by questionnaires from 1990. Study population consisted of 80 308 postmenopausal women (average follow-up: 10.1 years) including 549 documented idiopathic first venous thromboembolism. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated using Cox proportional models. Compared to never-users, past-users of hormone therapy had no increased thrombotic risk (HR=1.1; 95% CI: 0.8 to 1.5). Oral not transdermal estrogens were associated with increased thrombotic risk (HR=1.7; 95% CI: 1.1 to 2.8 and HR=1.1; 95% CI: 0.8 to 1.8; homogeneity: P=0.01). The thrombotic risk significantly differed by concomitant progestogens type (homogeneity: P<0.01): there was no significant association with progesterone, pregnanes, and nortestosterones (HR=0.9; 95% CI: 0.6 to 1.5, HR=1.3; 95% CI: 0.9 to 2.0 and HR=1.4; 95% CI: 0.7 to 2.4). However, norpregnanes were associated with increased thrombotic risk (HR=1.8; 95% CI: 1.2 to 2.7). In this large study, we found that route of estrogen administration and concomitant progestogens type are 2 important determinants of thrombotic risk among postmenopausal women using hormone therapy. Transdermal estrogens alone or combined with progesterone might be safe with respect to thrombotic risk.
Document type :
Journal articles
Complete list of metadatas

Cited literature [37 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01142846
Contributor : Pascale Sztajnbok <>
Submitted on : Thursday, April 16, 2015 - 10:11:20 AM
Last modification on : Sunday, October 25, 2020 - 7:07:22 AM
Long-term archiving on: : Monday, September 14, 2015 - 9:36:55 AM

File

Canonico_ATVB_2010.pdf
Files produced by the author(s)

Identifiers

Citation

Marianne Canonico, Agnès Fournier, Laure Carcaillon, Valérie Olié, Geneviève Plu-Bureau, et al.. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.: Hormone therapy and venous thromboembolism. Arteriosclerosis, Thrombosis, and Vascular Biology, American Heart Association, 2010, 30 (2), pp.340-5. ⟨10.1161/ATVBAHA.109.196022⟩. ⟨inserm-01142846⟩

Share

Metrics

Record views

830

Files downloads

1406